These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23302448)

  • 1. Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters.
    Hahn MK; Cohn T; Teo C; Remington G
    Clin Schizophr Relat Psychoses; 2013 Jan; 6(4):186-96. PubMed ID: 23302448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects.
    Hahn MK; Remington G; Bois D; Cohn T
    J Clin Psychopharmacol; 2010 Dec; 30(6):706-10. PubMed ID: 21105286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
    Behdani F; Hebrani P; Rezaei Ardani A; Rafee E
    Arch Iran Med; 2011 Jul; 14(4):270-5. PubMed ID: 21726104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial.
    Afshar H; Roohafza H; Mousavi G; Golchin S; Toghianifar N; Sadeghi M; Talaei M
    J Psychopharmacol; 2009 Mar; 23(2):157-62. PubMed ID: 18515465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Bellinghieri PM; Scimeca G; Cacciola M; Campolo D; Settineri S; Zoccali R
    J Psychopharmacol; 2011 May; 25(5):667-74. PubMed ID: 20615930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
    Correll CU; Maayan L; Kane J; Hert MD; Cohen D
    J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine augmented with glutamate modulators in refractory schizophrenia: a review and metaanalysis.
    Veerman SR; Schulte PF; Begemann MJ; Engelsbel F; de Haan L
    Pharmacopsychiatry; 2014 Sep; 47(6):185-94. PubMed ID: 25002291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate's effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial.
    Chandradasa M; Champika L; de Silva S; Kuruppuarachchi KALA
    Trials; 2017 Sep; 18(1):435. PubMed ID: 28931411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.
    Sommer IE; Begemann MJ; Temmerman A; Leucht S
    Schizophr Bull; 2012 Sep; 38(5):1003-11. PubMed ID: 21422107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study.
    Dursun SM; Deakin JF
    J Psychopharmacol; 2001 Dec; 15(4):297-301. PubMed ID: 11769825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of clozapine with another pharmacological agent: treatment for refractory schizophrenia in the 'real world'.
    Pai NB; Laidlaw M; Vella SC
    Acta Psychiatr Scand; 2012 Jul; 126(1):40-6. PubMed ID: 22432694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain.
    Ko YH; Joe SH; Jung IK; Kim SH
    Clin Neuropharmacol; 2005; 28(4):169-75. PubMed ID: 16062095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate for clozapine-induced seizures.
    Navarro V; Pons A; Romero A; Bernardo M
    Am J Psychiatry; 2001 Jun; 158(6):968-9. PubMed ID: 11384919
    [No Abstract]   [Full Text] [Related]  

  • 18. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
    Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
    J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
    Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
    Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM; Smith L
    Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.